AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Intro
This chapter explores the rising popularity of GLP-1 agonists like Ozempic and Wigovi for weight management, discussing their effectiveness beyond traditional dieting. It sets the stage for a debate on whether these medications should be available to everyone, presenting contrasting viewpoints from supporters and opponents within the healthcare field.